KA Imaging Signs Australian Distributor – Regional Health Care Group

Medical distribution company Regional Health Care Group (RHCG) will now be bringing KA Imaging’s innovative X-ray technologies to Australia and New Zealand.

This agreement ensures sole rights to RHCG as KA Imaging’s distributor.

“This is a fantastic opportunity for KA Imaging that moves us towards fulfilling our vision of innovative X-ray everywhere. We are thrilled to be expanding our business to the Australian market with our point-of-care, dual-energy solution,” said Amol Karnick, President and CEO.

In the past few months, KA Imaging has expanded its global presence. In addition to Australia, the company recently announced distributors in the United States and Mexico.

RHCG has been servicing the needs of the medical industry in Australia for more than 40 years. They are highly regarded in all clinical settings as a provider of medical consumables, contrast media and quality capital equipment.

“We are very excited to join forces with Canadian X-ray innovators KA Imaging. We are confident that the Reveal™ 35C technology will benefit the Australian healthcare system, especially with the results shown in current trials for detecting lung cancer and COVID-19 pneumonia,” said Stephen Doorey, General Manager of RHCG.

Healthcare is primarily funded through a public Medicare program in Australia and is provided to patients in both public and private sector hospitals and clinics. According to RHCG, the market size for diagnostic imaging services is said to be more than a $4B AUD.

Reveal 35C is the world’s first and only single exposure dual-energy flat panel X-ray detector that can be used in fixed, mobile, and portable applications. Its patented dual-energy technology only requires one shot to produce three images (DR, bone, and tissue) without motion artifacts.

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.